Karimian-Jazi, K., Wildemann, B., Diem, R., Schwarz, D., Hielscher, T., Wick, W., . . . Breckwoldt, M. O. (2018). Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI. Neurol Neuroimmunol Neuroinflamm.
Styl ChicagoKarimian-Jazi, Kianush, Brigitte Wildemann, Ricarda Diem, Daniel Schwarz, Thomas Hielscher, Wolfgang Wick, Martin Bendszus, a Michael O. Breckwoldt. "Gd Contrast Administration Is Dispensable in Patients With MS Without New T2 Lesions On Follow-up MRI." Neurol Neuroimmunol Neuroinflamm 2018.
Citace podle MLAKarimian-Jazi, Kianush, et al. "Gd Contrast Administration Is Dispensable in Patients With MS Without New T2 Lesions On Follow-up MRI." Neurol Neuroimmunol Neuroinflamm 2018.